Cohort of Patients With Pelvic Gynecological Cancer: Constitution of a Collection of Biological Samples With Radioclinical Characterization

Recruiting Observational Study
Pelvic Neoplasms Endometriosis
No Placebo Group Every participant receives an active treatment — no one gets a placebo. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Female
Study type
Observational
Participants needed
500 (estimated)
Sponsor
Centre Hospitalier Intercommunal Creteil · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
The management of pelvic gynecological cancers (PGC) is based on the determination of extension to guide treatments. The biology of the CGP is constantly evolving and personalized medicine adapted to this biology is currently in full development. For example, sequencing ovarian tumors can select patients who can benefit from anti-PARP therapy. There is therefore a need for patients to have biologi…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Diagnosis of pelvic gynecological cancer posed on initial histological analysis or during recurrence; * Or diagnosis of endometriosis on histology or imaging * Age ≥ 18 years; * Affiliation to the general social security scheme; * Consent signed. Exclusion Criteria: * Refusa…
Contacts

Cyril Touboul

0156017000

cyril.touboul@gmail.com

CONTACT